• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IVX 0.00% 0.3¢

INVION LIMITED

Invion Limited is an Australia-based life science company. The Company is engaged in the... Invion Limited is an Australia-based life science company. The Company is engaged in the research and development of Photosoft technology for the treatment of a range of cancers, atherosclerosis and infectious diseases. The Company is developing Photosoft technology as a Photodynamic Therapy (PDT). PDT uses non-toxic photosensitizers and light to selectively kill cancer cells and promote an anti-cancer immune response. PDT also offers an alternative treatment option aimed at achieving complete tumor regression and long-lasting remission. PDT has also demonstrated broad-spectrum activity across multiple infectious diseases, including bacteria, fungi and viruses. It holds the Australia and New Zealand license rights and distribution rights to Hong Kong and the rest of Asia Pacific, excluding China, Macau, Taiwan and Japan, to the Photosoft technology for all cancer indications. The Company’s wholly owned subsidiary is Epitech Dermal Science Pty Ltd.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
IVX 27/09/24 11 3.4K
27/09/24 Last post  chibadedignhk Comments Created with Sketch.  11  Views Created with Sketch.  3.4K 
IVX 19/09/24 18 5.5K
19/09/24 Last post  paulstocks Comments Created with Sketch.  18  Views Created with Sketch.  5.5K 
IVX 12/09/24 3 1.4K
Healthcare SECTOR NEWS

Recce targets Indonesia for its innovative anti-infective as Indo-Aussie ties strengthen!

RCE
02 Oct 2024
RECCE PHARMACEUTICALS LTD
12/09/24 Last post  Micksnuts Comments Created with Sketch.  3  Views Created with Sketch.  1.4K 
IVX 11/09/24 0 180
11/09/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  180 
IVX 11/09/24 0 149
11/09/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  149 
IVX 09/09/24 0 260
09/09/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  260 
IVX 09/09/24 0 187
09/09/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  187 
IVX 09/09/24 0 136
09/09/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  136 

See All Discussions arrow Created with Sketch.

Timeline

Investor Presentation
19 Sep 08:32
 
Ph 2 Prostate Cancer Results Strong Safety and 40% Response
18 Sep 08:49
 
Section 708A Cleansing Statement
11 Sep 15:32
 
Application for quotation of securities - IVX
11 Sep 15:31
 
Ethics Approval for Phase I/II Non-Meloma Skin Cancer Trial
11 Sep 08:40
 
Change of Director's Interest Notice - Alan Yamashita
09 Sep 09:10
 
View More arrow Created with Sketch.
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $20.29M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $15.46K 5.155M

Buyers (Bids)

No. Vol. Price($)
4 8137939 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 8207832 13
View Market Depth
Last trade - 16.10pm 02/10/2024 (20 minute delay) ?
IVX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.